within Pharmacolibrary.Drugs.ATC.C;

model C07AB11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 89 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>S-atenolol is the S-enantiomer of atenolol, a cardioselective beta-1 adrenergic receptor blocker used primarily for the management of hypertension, angina pectoris, and in some cases for secondary prevention after myocardial infarction. Atenolol is still clinically approved and widely used.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model parameters for healthy adult volunteers (mixed sex, non-elderly), oral administration.</p><h4>References</h4><ol><li><p>Clementi, WA, et al., &amp; Schwartz, S (1994). Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin). <i>Chirality</i> 6(3) 169–174. DOI:<a href=&quot;https://doi.org/10.1002/chir.530060303&quot;>10.1002/chir.530060303</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8024947/&quot;>https://pubmed.ncbi.nlm.nih.gov/8024947</a></p></li><li><p>Stoschitzky, K, et al., &amp; Lindner, W (1993). Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. <i>Chirality</i> 5(1) 15–19. DOI:<a href=&quot;https://doi.org/10.1002/chir.530050104&quot;>10.1002/chir.530050104</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8383518/&quot;>https://pubmed.ncbi.nlm.nih.gov/8383518</a></p></li><li><p>Egginger, G, et al., &amp; Stoschitzky, K (1993). Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study. <i>Chirality</i> 5(7) 505–512. DOI:<a href=&quot;https://doi.org/10.1002/chir.530050706&quot;>10.1002/chir.530050706</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8240927/&quot;>https://pubmed.ncbi.nlm.nih.gov/8240927</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07AB11;
